Accelerating clinical development of a live attenuated vaccine against<i>Salmonella</i>Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of<i>Salmonella</i>Paratyphi A infection in healthy adult volunteers
BMJ open